HDL Mimetic May Not Benefit Patients With Familial Hypoalphalipoproteinemia
Patients with very low levels HDL-cholesterol did not have improvements in carotid wall inflammation or dimensions when treated with an HDL mimetic.
Atherosclerosis
Platelet to Lymphocyte Ratio to Stratify Risk in CAD
The platelet to lymphocyte ratio may aide in stratifying risk in coronary artery disease.
Evolocumab Found to Reduce LDL-C, CV Risk in Patients With Metabolic Syndrome and Atherosclerotic Cardiovascular Disease
Evolocumab treatment in addition to statin therapy was found to lower cardiovascular risk in patients with metabolic syndrome and stable atherosclerotic cardiovascular disease.
Assessing Safety of Aspirin in High-Risk Patients With Atherosclerotic Cardiovascular Disease
Researchers sought to examine the safety of aspirin as a primary prevention method for atherosclerotic cardiovascular events in high-risk patients.
ACC Guidance for CV Specialists for the Initiation, Management of Glucose-Lowering Therapy in Type 2 Diabetes
Guidance is provided for cardiovascular specialists for the initiation and management of glucose-lowering therapies in patients with type 2 diabetes.
Corticosteroids and Traditional CV Risk Factors Worsen Atherosclerotic Indices in Patients With RA
In patients with rheumatoid arthritis, traditional cardiovascular risk factors and corticosteroids may increase the risk of worsening subclinical atherosclerosis indices over a 1-year period.
Nonfamilial Hypercholesterolemia Pediatric Dyslipidemia: Guidance for Management
The management of pediatric dyslipidemia should include weight regulation, diet optimization diet, and increased activity level.
Coronary Plaque Volume Inversely Associated With HDL-C in Atherosclerosis With Elevated TGL
Levels of high-density lipoprotein cholesterol were found to have an inverse relationship with baseline coronary plaque, total plaque, and total non-calcified plaque volumes in patients with dyslipidemia with elevated triglycerides.
Dyslipidemia Medication as Thrombosis Prophylaxis in COVID-19 With Familial Hypercholesterolemia?
The treatment of patients with familial hypercholesterolemia and COVID-19 with dyslipidemia medications may prevent the occurrence of thrombotic events.
Optical Frequency Domain Imaging Found to Detect More Atherosclerotic Plaques Than Angiography
Optical frequency domain imaging was found to accurately detect and assess angiographically unvisualized atherosclerotic plaques in the left main arterial wall.
-
Loading...
-
Loading...
Next post in Vascular Medicine
